1. Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis J Am Coll Cardiol. 2016;67(12):1459-1469. doi:10.1016/j.jacc.2015.10.104 Cohort Assembly Flow Diagram Assembly of cohort of patients with end-stage renal disease (ESRD) on dialysis who underwent percutaneous coronary intervention (PCI) with stenting after drug-eluting stents (DES) became available in the United States. BMS = bare-metal stent(s). Figure Legend:

2. Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis J Am Coll Cardiol. 2016;67(12):1459-1469. doi:10.1016/j.jacc.2015.10.104 Stent Type and Outcomes in Dialysis: Direct Comparison of DES and BMS in Patients on Dialysis Hazard ratios comparing drug-eluting stents (DES) with bare-metal stents (BMS) after percutaneous coronary intervention in patients with end-stage renal disease on dialysis for the specified outcomes using 2 different analytical approaches. Error bars represent 95% confidence intervals (CI). MI = myocardial infarction; Revasc = revascularization. Figure Legend:

3. Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis J Am Coll Cardiol. 2016;67(12):1459-1469. doi:10.1016/j.jacc.2015.10.104 Changing Patterns of DES Use in Patients on Dialysis From April 2003 to December 2010 Proportion of patients with end-stage renal disease on dialysis receiving drug-eluting stents (DES) or bare-metal stents (BMS) during percutaneous coronary intervention in 3 different DES eras: Transitional: April 24, 2003, to June 30, 2004; Liberal: July 1, 2004, to December 31, 2006; and Selective: January 1, 2007, to December 31, 2010. Figure Legend:

4. Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis J Am Coll Cardiol. 2016;67(12):1459-1469. doi:10.1016/j.jacc.2015.10.104 Temporal Analysis Comparing Outcomes by DES Era in Patients on Dialysis Kaplan-Meier curves by drug-eluting stent (DES) era, with unadjusted and adjusted hazard ratios (95% confidence intervals [CI]) comparing Transitional and Selective versus Liberal drug-eluting stent eras for the following 1-year outcomes after percutaneous coronary intervention: (A) death; (B) death or myocardial infarction (MI); and (C) death, MI, or repeat revascularization (RR). Figure Legend: